Novartis to disband cell & gene therapy unit, 120 jobs to go

ZURICH (Reuters) - Novartis is folding activities of its Cell and Gene Therapy unit into other business and research locations, eliminating 120 positions, the Swiss drugmaker said on Wednesday.